Digested Moringa oleifera Boiled Pod Exhibits Anti-Inflammatory Activity in Caco-2 Cells

REFERENCES

• Al-Sadi, R., S. Guo, D. Ye, K. Dokladny, T. Alhmoud, L. Ereifej, H.M. Said, and T.Y. Ma. 2013. Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J. Immunol. 190:1–10.
   Web of Science ®Google Scholar
• Al-Sadi, R., D. Ye, H. M. Said, and T. Y. Ma. 2010. IL-1β-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-κB pathway. Am. J. Pathol. 177:2310–2322.
   PubMed Web of Science ®Google Scholar
• Anwar, F., S. Latif, M. Ashraf, and A. Gilani. 2007. Moringa oleifera: A food plant with multiple medicinal uses. Phytotherapy Res. 21:17–25.
   PubMed Web of Science ®Google Scholar
• Azer, S. A. 2013. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. Eur. J. Gastroenterol. Hepatol. 25:271–281.
   PubMed Web of Science ®Google Scholar
• Bailey, C., R. Negus, A. Morris, P. Ziprin, R. Goldin, P. Allavena, D. Peck, and A. Darzi. 2007. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin. Exp. Metastasis. 24:121–130.
   PubMed Web of Science ®Google Scholar
• Balkwill, F. R., and A. Mantovani. 2012. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin. Cancer Biol. 22:33–40.
   PubMed Web of Science ®Google Scholar
• Barnes, P., and M. Karin. 1997. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066–1071.
   PubMed Web of Science ®Google Scholar
• Bauer, C., P. Duewell, C. Mayer, H. A.Lehr, K. A. Fitzgerald, M. Dauer, J. Tschopp, S. Endres, E. Latz, and M. Schnurr. 2010. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 59:1192–1199.
   PubMed Web of Science ®Google Scholar
• Bondurant, K. L., A. Lundgreen, J. S. Herrick, S. Kadlubar, R. K. Wolff, and M. L. Slattery. 2013. Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int. J. Cancer 132:905–915.
   PubMed Web of Science ®Google Scholar
• Bouguen, G., J. Chevaux, and L. Peyrin-Biroulet. 2011. Recent advances in cytokines: Therapeutic implications for inflammatory bowel diseases. World J. Gastroenterol. 17:547–556.
   PubMed Web of Science ®Google Scholar
• Brown, J. R., and R. N. DuBoi. 2005. COX-2: A molecular target for colorectal cancer prevention. J. Clin. Oncol. 23:2840–2855.
   PubMed Web of Science ®Google Scholar
• Budda, S., C. Butryee, S. Tuntipopipat, A. Rungsipipat, S. Wangnaithum, J. Lee, and P. Kupradinun. 2011. Suppressive effects of Moringa oleifera Lam pod against mouse colon carcinogenesis induced by azoxymethane and dextran sodium sulfate. Asian Pac. J. Cancer Prev. 12:3221–3228.
   PubMed Web of Science ®Google Scholar
• Casini-Raggi, V., L. Kam, Y. Chong, C. Fiocchi, T. Pizarro, and F. Cominelli. 1995. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanismof chronic intestinal inflammation. J. Immunol. 154:2434–2440.
   PubMed Web of Science ®Google Scholar
• Ferruzzi, M. G., J. L. Lumpkin, S. J. Schwartz, and M. Failla. 2006. Digestive stability, micellarization, and uptake of β-Carotene isomers by Caco-2 human intestinal cells. J. Agric. Food Chem. 54:2780–2785.
   PubMed Web of Science ®Google Scholar
• Fiocchi, C. 1998. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology115:182–205.
   PubMed Web of Science ®Google Scholar
• Hanauer, S., and F. Baert.1994. Medical therapy of inflammatory bowel disease. Med. Clin. North. Am. 78:1413–1426.
   PubMed Web of Science ®Google Scholar
• Hur, S. J., S. H. Kang, H. S. Jung, S. C.Kim, H. S. Jeon, I. H. Kim, and L. D. Lee. 2012. Review of natural products actions on cytokines in inflammatory bowel disease. Nutr Res. 32:801–816.
   PubMed Web of Science ®Google Scholar
• Mahajan, S. G., R. G. Mali, and A. A. Mehta. 2007. Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats. J. Immunotoxicol. 4:39–47.
   PubMed Web of Science ®Google Scholar
• Mahajan, S. G., and A. A. Mehta. 2008. Effect of Moringa oleifera Lam. seed extract on ovalbumin-induced airway inflammation in guinea pigs. Inhal Toxicol. 20:897–909.
   PubMed Web of Science ®Google Scholar
• Mahajan, S. G., and A. A. Mehta. 2010. Immunosuppressive activity of ethanolic extract of seeds of Moringa oleifera Lam. in experimental immune inflammation. J. Ethnopharmacol. 130:183–186.
   PubMed Web of Science ®Google Scholar
• Mahajan, S. G., and A. A. Mehta. 2011. Suppression of ovalbumin-induced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma. Eur. J. Pharmacol. 650:458–464.
   PubMed Web of Science ®Google Scholar
• McClellan, J. L., J. M. Davis, J. L. Steiner, S. D. Day, S. E. Steck, M. D. Carmichael, and E. A. Murphy. 2012. Intestinal inflammatory cytokine response in relation to tumorigenesis in the ApcMin/+ mouse. Cytokine 57:113–119.
   PubMed Web of Science ®Google Scholar
• McClellan, J. L., J. M. Davis, J. L. Steiner, R. T. Enos, S. H. Jung, J. A. Carson, M. M. Pena, K. A. Carnevale, F. G. Berger, and E. A. Murphy. 2012. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am. J. Physiol. Gastrointest. Liver Physiol. 303:G1087–G1095.
   PubMed Web of Science ®Google Scholar
• Muangnoi, C., P. Chingsuwanrote, P. Praengamthanachoti, S. Svasti, and S. Tuntipopipat. 2012. Moringa oleifera pod inhibits inflammatory mediator production by lipopolysaccharide-stimulated RAW 264.7 murine macrophage cell lines. Inflammation 35:445–455.
   PubMed Web of Science ®Google Scholar
• Ning. Y., P. C. Manegold, Y. K. Hong, W. Zhang, A. Pohl, G. Lurje, T. Winder, D., et al. 2011. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 128:2038–2049.
   PubMed Web of Science ®Google Scholar
• Pan, M.-H., C.-S. Lai, and C.-T. Ho. 2010. Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 1:15–31.
   PubMed Web of Science ®Google Scholar
• Panja, A., S. Goldberg, L. Eckmann, P. Krishen, and L. Mayer. 1998. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J. Immunol. 161:3675–3684.
   PubMed Web of Science ®Google Scholar
• Pithadia, A., and S. Jain. 2011. Treatment of inflammatory bowel disease (IBD). Pharmacol. Rep. 63:629–642.
   PubMed Web of Science ®Google Scholar
• Posmontier, B. 2011. The medicinal qualities of Moringa Oleifera. Holist. Nurs. Pract. 25:80–87.
   Google Scholar
• Pravda, J. 2005. Radical induction theory of ulcerative colitis. World J. Gastroenterol. 11:2371–2384.
   PubMed Web of Science ®Google Scholar
• Rutgeerts, P., B. G. Feagan, G. R. Lichtenstein, L. F. Mayer, S. Schreiber, J. F. Colombel, D. Rachmilewitz, et al. 2004. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease. Gastroenterology 126:402–413.
   PubMed Web of Science ®Google Scholar
• Sands, B. E., F. H. Anderson, C. N. Bernstein, W. Y.Chey, B. G. Feagan, R. N. Fedorak, M. A. Kamm, et al. 2004. Infliximab maintenance therapy for Fistulizing Crohn’s Disease. N. Engl. J. Med. 350:876–885.
   PubMed Web of Science ®Google Scholar
• Sergent, T., N. Piront, J. Meurice, O. Toussaint, and Y.-J. Schneider. 2010. Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem. Biol. Interact. 188:659–667.
   PubMed Web of Science ®Google Scholar
• Shimizu, M. 2010. Interaction between food substances and the intestinal epithelium. Biosci. Biotechnol. Biochem. 74:232–241.
   PubMed Web of Science ®Google Scholar
• Stallmach, A., S. Hagel, and T. Bruns. 2010. Adverse effects of biologics used for treating IBD. Best Pract. Res. Clin. Gastroenterol. 24:167–182.
   PubMed Web of Science ®Google Scholar
• Teng, Z., C. Yuan, F. Zhang, M. Huan, W. Cao, K. Li, J. Yang, D. Cao, S. Zhou, and Q. 2012. Intestinal absorption and first-pass metabolism of polyphenol compounds in rat and their transport dynamics in Caco-2 Cells. Plos ONE. 7:e29647.
   PubMed Web of Science ®Google Scholar
• Ullman, T. A., and S. H. Itzkowitz. 2011. Intestinal inflammation and cancer. Gastroenterology 140:1807–1816.
   PubMed Web of Science ®Google Scholar
• Vichai, V., and K. Kirtikara. 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 1:1112–1116.
   PubMed Web of Science ®Google Scholar
• Wu, B., K. Kulkarni, S. Basu, S. Zhang, and M. Hu. 2011. First-pass metabolism via UDP-glucuronosyltransferase: A barrier to oral bioavailability of phenolics. J. Pharm. Sci. 100:3655–3681.
   PubMed Web of Science ®Google Scholar
• Yang, G. Y., S. Taboada, and J. Liao J. 2009. Inflammatory bowel disease: A model of chronic inflammation-induced cancer. Inflammation and cancer. Methods Molec. Biol. 511:193–233.
   PubMedGoogle Scholar
• Zhu, H., and Y. Li. 2012. NAD(P)H: Quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions. Cardiovasc. Toxicol. 12:39–45.
   PubMed Web of Science ®Google Scholar